Incyte Correlations

Stocks . USA . 
Stock . Incyte
INCY Stock  USD 70.23  2.03  2.81%   
The correlation of Incyte is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Incyte moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Incyte moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Risk vs Return Analysis. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
  
The ability to find closely correlated positions to Incyte could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Incyte when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Incyte - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Incyte to buy it.

Moving together with Incyte

+0.84ACRXAcelRx Pharmaceuticals Earnings Call This WeekPairCorr
+0.61AMGNAmgen Inc Fiscal Quarter End 31st of March 2023 PairCorr
+0.85CDXSCodexis Fiscal Quarter End 31st of March 2023 PairCorr
+0.8CMRXChimerix Fiscal Quarter End 31st of March 2023 PairCorr
+0.82CPIXCumberland Pharmaceuticals Fiscal Quarter End 31st of March 2023 PairCorr
+0.7HCMHUTCHMED DRC Fiscal Quarter End 31st of March 2023 PairCorr
+0.62JNJJohnson Johnson Fiscal Quarter End 31st of March 2023 PairCorr
+0.81LPCNLipocine Fiscal Quarter End 31st of March 2023 PairCorr
+0.66MBIOMustang Bio Report 29th of March 2023 PairCorr

Moving against Incyte

-0.71AVDLAvadel Pharmaceuticals Report 30th of March 2023 PairCorr
-0.62ARDXArdelyx Fiscal Quarter End 31st of March 2023 PairCorr

Related Correlations

CDXS
CLXT
CPIX
ACRX
AVDL
CDXS
0.070.930.7-0.49
CDXS
CLXT
0.070.0-0.560.73
CLXT
CPIX
0.930.00.73-0.51
CPIX
ACRX
0.7-0.560.73-0.82
ACRX
AVDL
-0.490.73-0.51-0.82
AVDL
CDXS
CLXT
CPIX
ACRX
AVDL
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CPIX
+ 0.93
CDXS
AVDL
+ 0.73
CLXT
ACRX
+ 0.73
CPIX
ACRX
+ 0.7
CDXS
CLXT
+ 0.07
CDXS
CPIX
+ 0.0
CLXT
  
High negative correlations   
AVDL
- 0.82
ACRX
ACRX
- 0.56
CLXT
AVDL
- 0.51
CPIX
AVDL
- 0.49
CDXS
CPIX
- 0.0
CLXT

Risk-Adjusted Indicators

Nowadays, there is a big difference between Incyte Stock performing well and Incyte company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Incyte's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation		Jensen
Alpha		Sortino
Ratio		Treynor
Ratio		Semi
Deviation		Information
Ratio		Expected
Shortfall		Potential
Upside		Value
At Risk		Maximum
Drawdown
CDXS 3.30 (0.26)  0.00 (0.14)  0.00 (0.07)  0.00  6.42 (5.88)  23.45 
CLXT 8.42  1.91  0.18  1.55  7.94  0.14 (12.57)  18.75 (13.33)  109.92 
CPIX 2.32 (0.08)  0.00 (0.12)  0.00 (0.0216)  0.00  5.77 (3.82)  22.68 
ACRX 3.89 (1.54)  0.00 (2.05)  0.00 (0.26)  0.00  7.58 (9.21)  31.04 
AVDL 3.24  0.57  0.18  1.22  3.08  0.15 (3.79)  7.74 (5.01)  21.93 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Incyte without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Incyte Corporate Directors

Incyte corporate directors refer to members of an Incyte board of directors. The board of directors generally takes responsibility for the Incyte's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Incyte's board members must vote for the resolution. The Incyte board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

Already Invested in Incyte?

The danger of trading Incyte is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Incyte is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Incyte. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Incyte is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide. Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Incyte Stock analysis

When running Incyte price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95) 
Earnings Share
1.44
Revenue Per Share
15.291
Quarterly Revenue Growth
0.074
Return On Assets
0.069
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY